Korean J Urol.  1995 Feb;36(2):121-127.

Interleukin-4 Receptor Expression on Human Renal Cell Carcinoma Cell Lines by a Reverse Transcription-Polymerase Chain Reaction

Affiliations
  • 1Department of Urology, College of Medicine, Korea University, Seoul, Korea.
  • 2Department of Biochemistry, College of Medicine, Korea University, Seoul, Korea.

Abstract

Recently interleukin-4 (IL-4) has been suggested to be a promising therapeutic agent for the malignant tumors of both murine and human origin. The effect of IL-4 is mediated by IL-4 receptor (IL-4R), which has been shown to be expressed in many normal and tumor cell lines. We herein tested two cell lines of human renal cell carcinoma (RCC), Caki-1 and CURC-II, for the expression of IL-1R gene. On the reverse transcription-polymerase chain reaction study, both cell lines expressed IL-4R mRNA. The present study suggests that it would be worthwhile to investigate the anti-tumor effect of IL-4 on Caki-l and CIJRC-II, which may help to develop new therapeutic strategies for RCC using IL-4.

Keyword

Renal cell carcinoma; Interleukin-4; Receptor; Gene expression; Reverse transcription-polymerase chain reaction

MeSH Terms

Carcinoma, Renal Cell*
Cell Line*
Cell Line, Tumor
Gene Expression
Humans*
Interleukin-4*
Receptors, Interleukin-4
RNA, Messenger
Interleukin-4
RNA, Messenger
Receptors, Interleukin-4
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr